Upregulation of Bax protein and increased DNA degradation in ALS spinal cord motor neurons

Acta Neurologica Scandinavica

Volumn 100, Issue 5, 1999, Pages 317-321

  Ekegren, Titti ^a   Grandstrom E ^a   Lindholm, D ^b   Aquilonius, S M ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

Amyotrophic lateral sclerosis (ALS); Bax; Bcl 2; ICH 1(L); Neurodegeneration; TUNEL

Indexed keywords

CYSTEINE PROTEINASE; DNA; PROTEIN BAX; PROTEIN BCL 2;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA DEGRADATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREACTIVITY; MALE; MOTONEURON; NERVE CELL DEGENERATION; PROTEIN EXPRESSION; SPINAL CORD; SPINAL CORD NERVE CELL;

EID: 0032862513     PISSN: 00016314     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0404.1999.tb00403.x     Document Type: Article

References (20)

1. LO AC, HOUENOU LJ, OPPENHEIM RW. Apoptosis in the nervous system: morphological features, methods, pathology, and prevention. Arch Histol Cytol 1995;58(2):139-49.
2. TROOST D, ATEN J, MORSINK F, dE JONG JMBV. Apoptosis in amyotrophic lateral sclerosis is not restricted to motor neurons. Bcl-2 expression is increased in unaffected post-central gyrus. Neuropathol Appl Neurobiol 1995;21:498-504.
3. Y and nick-end labeling are positive in spinal motor neurons in amyotrophic lateral sclerosis. Acta Neuropathol 1994;88:207-11.
4. MU X, HE J, ANDERSON DW, TROJANOWSKI JQ, SPRINGER JE. Altered expression of bcl-2 and bax mRNA in amyotrophic lateral sclerosis spinal cord motor neurons. Ann Neurol 1996;40:379-86.
5. AKAGI T, KONDO E, YOSHINO T. Expression of Bcl-2 protein and Bcl-2 mRNA in normal and neoplastic lymphoid tissues. Leuk Lymphoma 1994;13:81-7.
6. l or bax proteins in multidrug-resistant MCF-7/Adr human breast cancer cells. Int J Cancer 1996;67:608-14.
7. KORSMEYER SJ, SHUTTER JR, VEIS DJ, MERRY DE, OLTVAI ZN. Bcl-2/Bax: a rheostat that regulates an anti-oxidant pathway and cell death. Cancer Biol 1993;4:327-32.
8. VEKRELLIS K, MCCARTHY MJ, WATSON A, WHITFIELD J, RUBIN LL, HAM J. Bax promotes neuronal cell death and is downregulated during the development of the nervous system. Development 1997;124:1239-49.
9. WANG L, MIURA M, BERGERON L, ZHU H, YUAN J. Ich-l, an Icelced-3-related gene, encodes both positive and negative regulators of programmed cell death. Cell 1994;78:739-50.
10. BREDESEN DE. Neural apoptosis. Ann Neurol 1995;38:839-51.
11. GAVRIELI Y, SHERMAN Y, BEN-SASSON SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992;119(3):493-501.
12. TEWS DS, GOEBEI HH, MEINCK HM. DNA-fragmentation and apoptosis-related proteins of muscle cells in motor neuron disorders. Acta Neurol Scand 1997;96:380-6.
13. ADEM A, EKBLOM J, GILLBERG P-G et al. Insulin-like growth factor-1 receptors in human spinal cord: changes in amyotrophic lateral sclerosis. J Neural Transm 1994;97:73-84.
14. ABERCROMBIE M. Estimation of nuclear population from microtome sections. Anat Rec 1946;94:239-47.
15. AQUILONIUS S-M, ECKERNÄS S-Å, GILLBERG P-G. Topographical localization of choline acetyltransferase within the human spinal cord and a comparison with some other species. Brain Res 1981;211:329-40.
16. FONNUM F. Recent developments in biochemical investigations of cholinergic transmission. Brain Res 1973;62:497-507.
17. NAGATA Y, OKUYA M, WATANABE R, HONDA M. Regional distribution of cholinergic neurons in human spinal cord transactions in patients with and without motor neuron disease. Brain Res 1982;244:223-9.
18. ROTHSTEIN JD, TSAI G, KUNCI RW et al. Abnormal excitatory amino acid metabolism in Amyotrophic lateral sclerosis. Ann Neurol 1990;28:18-25.
19. PARADIS E, DOUILLARD H, KOUTROUMANIS M, GOODYER C, LEBLANC A. Amyloid β Peptide of Alzheimer's disease downregulates Bcl-2 and upregulates Bax expression in human neurons. J Neurosci 1996;16(23):7533-9.
20. VYAS S, JAVOY-AGID F, HERRERO M-T et al. Expression of Bcl-2 in adult human brain regions with special reference to neurodegenerative disorders. J Neurochem 1997;69:223-31.